» Articles » PMID: 16160762

DNA Fingerprinting Pattern and Susceptibility to Antifungal Drugs in Cryptococcus Neoformans Variety Grubii Isolates from Barcelona City and Rural Environmental Samples

Overview
Journal Mycopathologia
Date 2005 Sep 15
PMID 16160762
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptococcus neoformans var. grubii (serotype A) was isolated from 12 soil samples mixed with pigeon droppings (16.9%) from 71 soil samples in Barcelona and rural areas of Catalonia. C. neoformans was not isolated from indoor dust and Eucalyptus debris. PCR fingerprinting was performed in 22 representative isolates and all of them corresponded to the VNI pattern. Susceptibility testing for the 22 isolates of C. neoformans var. grubii showed that all of them were susceptible to amphotericin B. Three isolates presented MICs (Minimal Inhibitory Concentrations) > or = 1 microg/ml to Itraconazole, five MICs > or = 1 microg/ml to ketoconazole and four were fluconazole resistant, (MICs > or = 64 microg/ml), while three of them were shown to have MICs > or = 1 microg/ml to voriconazole. In spite that all isolates presented the same DNA fingerprinting pattern, the susceptibility to antifungals is very variable. The possibility of acquiring cryptococcosis infection with primarily resistant environment strains is feasible.

Citing Articles

Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.

Matos C, de Souza Andrade A, Oliveira N, Barros T Eur J Clin Microbiol Infect Dis. 2012; 31(7):1647-52.

PMID: 22278291 PMC: 3364408. DOI: 10.1007/s10096-011-1488-3.

References
1.
Franzot S, Hamdan J . In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob Agents Chemother. 1996; 40(3):822-4. PMC: 163211. DOI: 10.1128/AAC.40.3.822. View

2.
Franzot S, Salkin I, Casadevall A . Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol. 1999; 37(3):838-40. PMC: 84578. DOI: 10.1128/JCM.37.3.838-840.1999. View

3.
Staib F, Seibold M, Antweiler E, Frohlich B, Weber S, BLISSE A . The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentralbl Bakteriol Mikrobiol Hyg A. 1987; 266(1-2):167-77. DOI: 10.1016/s0176-6724(87)80030-5. View

4.
Colom M, Frases S, Ferrer C, Jover A, Andreu M, Torres-Rodriguez J . [First local case of human cryptococcosis in Spain caused by Cryptococcus neoformans var. gattii]. Rev Iberoam Micol. 2004; 20(4):181. View

5.
Meyer W, Marszewska K, Amirmostofian M, Igreja R, Hardtke C, Methling K . Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological.... Electrophoresis. 1999; 20(8):1790-9. DOI: 10.1002/(SICI)1522-2683(19990101)20:8<1790::AID-ELPS1790>3.0.CO;2-2. View